Publication Name	World Journal of Hepatology
Manuscript ID	85011
Country	United States

Received	2023-04-07 19:33
Peer-Review Started	2023-04-07 19:53
To Make the First Decision
Return for Revision	2023-06-25 05:57
Revised	2023-07-17 15:47
Second Decision	2023-08-23 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-08-23 08:35
Articles in Press	2023-08-23 08:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-09-05 01:55
Publish the Manuscript Online	2023-09-22 12:27

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review
Manuscript Source	Invited Manuscript
All Author List	Mark W Russo
Funding Agency and Grant Number
Corresponding Author	Mark W Russo, FAASLD, AGAF, FACG, MD, Professor, Department of Hepatology, Atrium Health Wake Forest, 6th Floor MMP, 1025 Morehead Medical Dr, Charlotte, NC 28204, United States. mark.russo@atriumhealth.org
Key Words	Cholestatic; Survival; Mortality; Predict; Cirrhosis; Decompensation
Core Tip	Several noninvasive prognostic models have been validated that improve upon serum alkaline phosphatase and the Mayo risk score or include subgroups of patients not validated by these tests. The UK-PSC score has superior test performance compare to the Mayo risk score for short and long term transplant free survival. The Primary sclerosing risk estimate tool (PREsTo) has excellent test performance for risk of hepatic decompensation. The Amsterdam-Oxford model includes patients with small duct primary sclerosing cholangitis (PSC) and PSC-autoimmune hepatitis overlap. Elastography and magnetic resonance imaging show promise as prognostic tools.
Publish Date	2023-09-22 12:27
Citation	Russo MW. Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review. World J Hepatol 2023; 15(9): 1013-1020
URL	https://www.wjgnet.com/1948-5182/full/v15/i9/1013.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i9.1013

Full Article (PDF)	WJH-15-1013-with-cover.pdf
Full Article (Word)	WJH-15-1013.docx
Manuscript File	85011_Auto_Edited-LJH-JLW.docx
Answering Reviewers	85011-Answering reviewers.pdf
Audio Core Tip	85011-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	85011-Conflict-of-interest statement.pdf
Copyright License Agreement	85011-Copyright license agreement.pdf
Peer-review Report	85011-Peer-review(s).pdf
Scientific Misconduct Check	85011-Bing-Liu JH-2.png
Scientific Misconduct Check	85011-CrossCheck.png
Scientific Editor Work List	85011-Scientific editor work list.pdf
CrossCheck Report	85011-CrossCheck report.pdf